Ming Yan - Feb 3, 2023 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
Chief Technology Officer, Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Ming Yan
Stock symbol
CTKB
Transactions as of
Feb 3, 2023
Transactions value $
-$14,742
Form type
4
Date filed
2/7/2023, 05:31 PM
Previous filing
Jan 20, 2023
Next filing
Feb 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Sale -$14.6K -1.08K -0.01% $13.50 7.95M Feb 3, 2023 Direct F1
transaction CTKB Common Stock Sale -$149 -11 0% $13.51 7.95M Feb 3, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2022.